D-0359-2022 Class II Terminated

Recalled by Ascend Laboratories, LLC — Parsippany, NJ

FDA drug recall D-0359-2022 was initiated by Ascend Laboratories, LLC on Dec 21, 2021 and is designated Class II. Reason for recall: Failed impurities/degradation specifications The recall status is terminated (terminated Apr 13, 2023). Affected quantity: 42,698 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 12, 2022
Initiation Date
Dec 21, 2021
Termination Date
Apr 13, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
42,698 bottles

Product description

Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, NDC 67877-584-50

Reason for recall

Failed impurities/degradation specifications

Distribution pattern

USA nationwide.

Code information

Lot #: 20140293, Exp Dec 2021; 20141525, 20141526, 20141527, Exp Mar 2022; 20143019, 20143020, 20143021, 20143022, Exp July 2022; 20144759, 20144760, 20144761, Exp Nov 22

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0359-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0359-2022. Report a data issue: hello@regdatalab.com.